ScinoPharm® offers a full spectrum of capabilities starting from the earliest stage of synthesizing potential NCE's through large-scale commercial operation. Specific capabilities include:
|
|
ScinoPharm's capable research and development teams, located in both Taiwan and China, in conjunction with its FDA approved state-of-the art cGMP facilities in Taiwan, can assure on-time development of non-infringing patent processes and timely delivery of high quality, price competitive API's to ScinoPharm's downstream customers
More information >
|
|
ScinoPharm has expanded its chemistry-based API business into the biopharmaceutical area. Our principal focus is on development of a number of biopharmaceutical products and their production technologies.
More information > |
Product List
